These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8133915)

  • 21. The end stage renal disease program.
    Stark P
    N Engl J Med; 1993 Jul; 329(2):140. PubMed ID: 8510702
    [No Abstract]   [Full Text] [Related]  

  • 22. Survival among patients with kidney failure in Jalisco, Mexico.
    Garcia-Garcia G; Briseño-Rentería G; Luquín-Arellan VH; Gao Z; Gill J; Tonelli M
    J Am Soc Nephrol; 2007 Jun; 18(6):1922-7. PubMed ID: 17494884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bundling and its potential impact on dialysis service providers.
    Sullivan J
    Nephrol News Issues; 2008 Oct; 22(11):12, 14, 16-7. PubMed ID: 19009855
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of chronic kidney disease in primary health care: position paper of the European Forum for Primary Care.
    Rosenberg M; Kalda R; Kasiulevicius V; Lember M;
    Qual Prim Care; 2008; 16(4):279-94. PubMed ID: 18718165
    [No Abstract]   [Full Text] [Related]  

  • 25. How can the poor outcomes for diabetic dialysis patients be improved?
    Sehgal AR
    Semin Dial; 2004; 17(3):188-90. PubMed ID: 15144541
    [No Abstract]   [Full Text] [Related]  

  • 26. The ESRD regulatory landscape: a primer and resource. Part 1.
    Robers S
    Nephrol News Issues; 2002 Dec; 16(13):29-33, 53. PubMed ID: 12596328
    [No Abstract]   [Full Text] [Related]  

  • 27. Mortality: is it fair to compare PD & HD?
    Nolph K
    Nephrol News Issues; 1996 Feb; 10(2):14. PubMed ID: 8709990
    [No Abstract]   [Full Text] [Related]  

  • 28. Strategies for influencing outcomes in pre-ESRD and ESRD patients.
    Burkart JM; Pereira BJ; Parker TF
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S2-3. PubMed ID: 11443764
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical performance measures report identifies areas for improvement.
    Nephrol News Issues; 2005 Aug; 19(9):30-2. PubMed ID: 16173301
    [No Abstract]   [Full Text] [Related]  

  • 30. Dialysis and mortality: does it matter where you live?
    Rodriguez RA
    Clin J Am Soc Nephrol; 2012 Jul; 7(7):1055-7. PubMed ID: 22723448
    [No Abstract]   [Full Text] [Related]  

  • 31. Ownership of dialysis facilities and patients' survival.
    Ruma JJ; Wick GS
    N Engl J Med; 2000 Apr; 342(14):1055; author reply 1055-6. PubMed ID: 10755902
    [No Abstract]   [Full Text] [Related]  

  • 32. Taken to the woodshed...again.
    Neumann ME
    Nephrol News Issues; 2015 Mar; 29(3):8. PubMed ID: 26480637
    [No Abstract]   [Full Text] [Related]  

  • 33. Ownership of dialysis facilities and patients' survival.
    Bander SJ; Lazarus JM; Lindenfeld SM
    N Engl J Med; 2000 Apr; 342(14):1054; author reply 1055-6. PubMed ID: 10755899
    [No Abstract]   [Full Text] [Related]  

  • 34. The obesity epidemics in ESRD: from wasting to waist?
    Zoccali C
    Nephrol Dial Transplant; 2009 Feb; 24(2):376-80. PubMed ID: 18952700
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems of an artificial dialysis center].
    Yoshitoshi Y
    Nihon Rinsho; 1968 Oct; 26(10):2273-8. PubMed ID: 5752002
    [No Abstract]   [Full Text] [Related]  

  • 36. [Factors determining the modality selection in dialysis].
    Kessler M; Chanliau J
    Nephrologie; 2000; 21(2):45-6. PubMed ID: 10798203
    [No Abstract]   [Full Text] [Related]  

  • 37. The end stage renal disease program.
    Himmelstein DU; Woolhandler S
    N Engl J Med; 1993 Jul; 329(2):139-40; author reply 140-1. PubMed ID: 8510701
    [No Abstract]   [Full Text] [Related]  

  • 38. [Registries of renal patients: a new perspective].
    Morlans M
    Med Clin (Barc); 1984 Dec; 83(18):756-8. PubMed ID: 6394920
    [No Abstract]   [Full Text] [Related]  

  • 39. Dialysis therapy.
    Man NK; Jungers P
    N Engl J Med; 1998 Oct; 339(14):1004; author reply 1005. PubMed ID: 9766987
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant erythropoietin. The effect of the marketplace on socialized patient care.
    Besarab A; Erslev AJ
    ASAIO J; 1993; 39(2):85-6. PubMed ID: 8324265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.